Prostatis Group’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Prostatis Group's JNJ Position: Q2 2026 in Review
Prostatis Group increased its Johnson & Johnson (JNJ) stake by 131% in Q2 2026, buying an estimated $859K and bringing the position to 6,495 shares worth $1.65M. The position accounts for 0.38% of the portfolio, ranked #54.
Prostatis Group first reported a position in JNJ in Q4 2019 and has held it in 21 quarters since. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Prostatis Group held 6,495 shares of Johnson & Johnson worth $1.65M as of Q2 2026.
- Prostatis Group bought 3,687 Johnson & Johnson shares in Q2 2026, an estimated $859K.
- Johnson & Johnson made up 0.38% of Prostatis Group's portfolio in Q2 2026, its #54 holding.
- Prostatis Group first reported a position in Johnson & Johnson in Q4 2019 and has held it in 21 quarters since.
- 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.